SCHEMBL5743374

SCHEMBL5743374

NC(Cc1ccccc1)C(=O)NC(=O)c1ccccc1

nearest known ligand 0.62

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
NAMPT P43490 4/20 0.62
SLC7A5 Q01650 2/20 0.58
ALPI P09923 1/20 0.58
PKM P14618 1/20 0.58
PTGS1 P23219 1/20 0.58
XIAP P98170 1/20 0.58
TPH1 P17752 2/20 0.56
SLC15A1 P46059 1/20 0.54
CTSC P53634 1/20 0.54
LTA4H P09960 1/20 0.51
CTRB1 P17538 5/20 0.50
TP53 P04637 1/20 0.50
ALDH1A1 P00352 1/20 0.49
ALOX12 P18054 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7700701 1.00 NAMPT (0.62) NAMPTSLC7A5ALPIPKMPTGS1
SCHEMBL11425334 0.91 SLC7A5 (0.57) NAMPTSLC7A5ALPIPKMPTGS1
Hydrochloric Acid SCHEMBL7268206 0.88 NAMPT (0.58) NAMPTSLC7A5ALPIPKMPTGS1
SCHEMBL17844273 0.88 ALPI (0.68) NAMPTSLC7A5ALPIPKMPTGS1
SCHEMBL7698097 0.87 LNPEP (0.60) LTA4HALDH1A1
SCHEMBL31746131 0.86 ECE1 (0.58) NAMPTALPIALDH1A1
SCHEMBL10898440 0.86 SLC7A5 (0.53) NAMPTSLC7A5ALPIPKMPTGS1
SCHEMBL14493298 0.86 ECE1 (0.58) NAMPTALPIALDH1A1
SCHEMBL903518 0.85 TACR1 (0.57) NAMPTSLC7A5ALPIPKMPTGS1
SCHEMBL28056454 0.85 TACR1 (0.57) NAMPTSLC7A5ALPIPKMPTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1670804-A2 HETEROBICYCLIC COMPOUNDS AS PHARMACEUTICALLY ACTIVE AGENTS GPC Biotech AG (DE) 2006-06-21 EP claimed
WO-2005023818-A2 HETEROBICYCLIC COMPOUNDS AS PHARMACEUTICALLY ACTIVE AGENTS GPC BIOTECH AG (DE) 2005-03-17 WO claimed
CN-113226377-B Antibody drug conjugates comprising an eltrinastine derivative 法马马有限公司 2022-10-18 CN disclosed